Manufacturers provide long-term data on rejected…
31 July, 2024
0 Comments
1 category
medicine Wednesday, July 31, 2024 Tokyo/Cambridge – The beneficial effects of the antibody lecanemab, which is approved in the USA, Japan, China, South Korea and Israel, but not in Europe, for the treatment of early